JSW Life Sciences GmbH

Also known as: JSW Lifesciences | JSW Life Sciences | JSW-Life Sciences | JSW Research Forschungslabor GmbH | JSW-Research Forschungslabor GmbH, Parkring 12, 8074 Grambach

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Oct 1, 2005

Last known activity

Sep 1, 2009

Acquired by QPS on Aug 29, 2012

Timeline

1990s

Jan 1, 1999
JSW Life Sciences GmbH— Founded

2010s

Aug 29, 2012
QPS— Acquired By

Drugs by trial phase (4 distinct, 3 trials)

Phase 3 (2 own, 0 via acquisition)

sodium chloride
cenegermin-bkbj

Phase 2 (2 own, 0 via acquisition)

lornoxicam
tideglusib

Indications

Studied for

Alzheimer Disease
Stroke

Recent trials (5)

NCT01117948Study directorPhase 2Sep 1, 2009
NCT01117948Lead sponsorPhase 2Sep 1, 2009
NCT00948259Study directorPhase 1/Phase 2Dec 1, 2008
NCT00840671Study directorPhase 3Oct 1, 2005
NCT00840671CollaboratorPhase 3Oct 1, 2005

Details

Founded: Grambach, AT Jan 1, 1999
Last known activity: Sep 1, 2009